In the lead up to World Tuberculosis (TB) Day this Saturday, March 24, the TB Alliance announced the launch of a new trial to test a combination drug regimen in patients with drug-sensitive TB as well as patients with multidrug-resistant (MDR) TB – the first time this has ever been done. Called “NC-002,” the eight-week […]
Plan to develop new vaccines could help stop TB in our children’s lifetimes
The following is a guest blog post by Dr. Lucica Ditiu, executive secretary of the Stop TB Partnership, commenting on the newly released document Tuberculosis Vaccines: A Strategic Blueprint for the Next Decade, reflecting the consensus of members of the TB vaccine research and development community to develop new vaccines that could help stop TB in our children’s lifetimes.
HIV
While plan will target 48 “hot spots” with services, and people at high risks with PrEP, will it change policies that fuel HIV? More details are […]
Tuberculosis
With the release of a “pre-final text” of updated guidelines for treatment of multidrug- and rifampicin-resistant tuberculosis, the World Health Organization made official substantial changes to […]
Research & Development
A trial to test the safety of, and immune response prompted by, the latest candidate for a vaccine to protect against Zika virus infection has begun […]
Policy
Drawing on previously published findings and on-the-ground interviews, a report from Planned Parenthood details damage to global health gains, including in closed programs, weakened civil society, […]